Research progress on serological markers of non-alcoholic fatty liver disease / 中国综合临床
Clinical Medicine of China
; (12): 128-132, 2024.
Article
en Zh
| WPRIM
| ID: wpr-1026705
Biblioteca responsable:
WPRO
ABSTRACT
The incidence of non-alcoholic fatty liver disease (NAFLD) is increasing year by year, and it has become a serious public health problem that threatens human health.NAFLD patients can progress from simple steatosis to non-alcoholic steatohepatitis (NASH), liver fibrosis, and even cirrhosis without intervention. Therefore, early diagnosis and treatment are particularly important.Liver biopsy is the gold standard for diagnosing NAFLD, but its limitations such as invasion, bleeding, and high cost limit its widespread clinical application. There is an urgent need for sensitive and convenient non-invasive diagnostic methods to achieve early diagnosis and treatment of NAFLD.This article provides a review of the progress in serological diagnostic methods for NAFLD both domestically and internationally in recent years.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Clinical Medicine of China
Año:
2024
Tipo del documento:
Article